Assessing novel partner antimicrobials to protect ceftriaxone against gonococcal resistance: An in vitro evaluation
The low MICs of zoliflodacin and pristinamycin for the three ceftriaxone-resistant strains suggest that these antimicrobials could be used as partner drugs with ceftriaxone to reduce the probability of ceftriaxone resistance spreading in areas with a high prevalence of ceftriaxone resistance.
Authors
- Tessa de Block (ORCID: https://orcid.org/0000-0003-3294-0147)
- Irith De Baetselier (ORCID: https://orcid.org/0000-0002-1804-252X)
- Saïd Abdellati (ORCID: https://orcid.org/0000-0002-9620-8257)
- Dorien Van den Bossche (ORCID: https://orcid.org/0000-0002-7545-4360)
- Sheeba Santhini Manoharan-Basil (ORCID: https://orcid.org/0000-0001-8421-5137)
- Zina Gestels (ORCID: https://orcid.org/0000-0001-8790-3517)
- Chris Kenyon (ORCID: https://orcid.org/0000-0002-2557-8998)
- Yuliia Baranchyk (ORCID: https://orcid.org/0009-0002-5790-0096)
Institutions
- University of Cape Town (ZA)
- Instituut voor Tropische Geneeskunde (BE)
Publication Details
- Journal
- International Journal of STD & AIDS
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1177/09564624241280082
- Citations
- 1
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.34